OAC0806 | Programmatic outcomes of pre-exposure prophylaxis (PrEP) in a resource constraint high HIV incidence setting in Eswatini | Oral abstract session with live Q&A | C35 |
OAC0807 | PrEP continuum of care and new HIV infections: Long-term follow-up in a large clinical cohort | Oral abstract session with live Q&A | C36 |
OACLB0101 | HPTN 083 interim results: Efficacy of pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB-LA) is maintained across regions and key populations | Oral abstract session with live Q&A | C43 |
OACLB0102 | HIV infection and unsafe injection practice among children in Sindh, Pakistan: A case-control study of an outbreak | Oral abstract session with live Q&A | C5 |
OACLB0103 | Impact of physical distancing due to COVID-19 on HIV pre-exposure prophylaxis (PrEP) use and sexual behaviour among gay and bisexual men in Australia: Implications for trends in HIV and other sexually transmissible infections | Oral abstract session with live Q&A | C56 |
OACLB0104 | Impact of COVID-19 on HIV preexposure prophylaxis care at a Boston community health center | Oral abstract session with live Q&A | C56 |
OACLB0105 | Cluster randomized trial of an HIV self-testing intervention to promote partner testing and safer sexual behavior among women at high risk of HIV infection in Kenya | Oral abstract session with live Q&A | C34 |
OAD0102 | 'Living with HIV does not mean you should lose hope': The importance of assessing resilience within the PLHIV Stigma Index 2.0 | Oral abstract session with live Q&A | D8 |
OAD0103 | Fragile lives. Gay shame, HIV stigma, substance use and structural factors greatly affect Latino gay men living with HIV in San Francisco, California: Implications for mental health interventions globally | Oral abstract session with live Q&A | D10 |
OAD0104 | Family support as a source of resilience to counter HIV-related stigma among adults on antiretroviral therapy in urban Zimbabwe | Oral abstract session with live Q&A | D10 |